Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Post-Marketing Clinical Follow-up of an Anular Closure System (Barricaid®) to Confirm Comparability of Outcome Between Devices With Subcomponents From Two Different Suppliers

NCT03180749 is registered in ClinicalTrials.gov with Intrinsic Therapeutics as lead sponsor.

NCT NCT03180749
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03180749 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Post-Marketing Clinical Follow-up of an Anular Closure System (Barricaid®) to Confirm Comparability of Outcome Between Devices With Subcomponents From Two Different Suppliers
Lead sponsor
Intrinsic Therapeutics
Phase
Observational
Overall status
Unknown status
Start date
March 2, 2017
Completion date
September 30, 2024
Enrollment
90 (actual)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

annular tear of lumbar disc, lumbar disc herniation